Recent exceptional negative changes in investment behavior have affected Exact Sciences Corporation (NASDAQ: EXAS): its longer term price trend turned down, its shorter term price trend turned down, and negative upside/downside volume developed.
Exact Sciences Corporation (NASDAQ: EXAS) suffers from slight negative changes in fundamentals: the consensus estimate for December, 2025 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, EXAS is expected to be a modest Value Builder.
Exact Sciences has a current Value Trend Rating of D (Negative). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Exact Sciences has a neutral Power Rating of 44 and a slightly negative Appreciation Score of 35, and the Negative Value Trend Rating results.
Recent Price Action
Exact Sciences Corporation (NASDAQ: EXAS) stock closed at $51.48 on 11/8/24 after a decline of -3.3%. Moreover, trading volume in this decline was unusually high at 183% of normal. The stock has declined -25.3% during the last week and has performed in line with the market over the last nine months.
Be the first to comment